Boston Scientific (BSX) Minority Interest (2023 - 2026)

Boston Scientific (BSX) has 4 years of Minority Interest data on file, last reported at $240.0 million in Q1 2026.

• For the quarter ending Q1 2026, Minority Interest rose 3.0% year-over-year to $240.0 million; the trailing twelve-month figure through Mar 2026 stood at $240.0 million (up 3.0% YoY), and the FY2025 full-year result was $239.0 million, up 2.58% from the prior year.
• Minority Interest held at $240.0 million in Q1 2026, from $239.0 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $259.0 million in Q1 2023 to a low of $233.0 million in Q4 2024.
• A 4-year average of $242.5 million and a median of $240.0 million in 2026 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest retreated 8.11% in 2024 and advanced 3.0% in 2026, its largest moves.
• Tracing BSX's Minority Interest over 4 years: stood at $248.0 million in 2023, then declined by 6.05% to $233.0 million in 2024, then rose by 2.58% to $239.0 million in 2025, then increased by 0.42% to $240.0 million in 2026.
• Business Quant data shows BSX's Minority Interest at $240.0 million in Q1 2026, $239.0 million in Q4 2025, and $236.0 million in Q3 2025.